相关实验视频
Updated: Jun 12, 2025

07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
48.1K
双重Kv7.2/3-TRPV1调节剂抑制了恶性感受器的过度兴奋性,并缓解疼痛,没有与标相关的副作用
Adi Raveh1, Yefim Pen1, Alon Silberman1
1Bsense Bio Therapeutics Ltd., Ness Ziona, Israel.
Pain
|September 26, 2024
概括
新的双重作用化合物同时激活Kv7.2/3通道并抑制TRPV1通道,为慢性疼痛提供了一种新的治疗方法. 这种双重调制在动物模型中显示出显著的疼痛缓解,没有常见的副作用.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 疼痛研究 疼痛研究
背景情况:
- 慢性疼痛影响数以百万计的人,目前的治疗方法通常因疗效或副作用而受到限制.
- 涉及TRPV1和Kv7.2/3通道的nociceptor过度兴奋性是疼痛机制的核心.
- 之前针对TRPV1或Kv7.2/3的药物开发单独面临副作用概况的挑战.
研究的目的:
- 识别和描述具有双重作用机制的新型小分子类似物.
- 为了研究Kv7.2/3和TRPV1通道的同时调制.
- 评估这种双调制在慢性疼痛治疗中的治疗潜力.
主要方法:
- 对三种新型小分子类似物进行药理分析.
- 在体外测定以评估Kv7.2/3激活和TRPV1抑制.
- 在急性和慢性疼痛的动物模型中进行体内研究,以评估镇痛功效.
主要成果:
- 同类药物证明了Kv7.2/3的同时激活和TRPV1.1的强烈抑制.
- 在多种疼痛模型中,化合物在体内实现了显著的镇痛作用.
- 这种新的作用机制与已知的特定类别的副作用无关.
结论:
- Kv7.2/3和TRPV1的双调节代表了慢性疼痛的有前途的治疗策略.
- 对特定的恶性感受体亚群的选择性向可能解释了有利的疗效和安全性.
- 这些化合物需要进一步的临床前和临床开发来治疗慢性疼痛.
更多相关视频
相关概念视频
Analgesia and Pain Management
551
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
551
Nociception
27.8K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.8K
Pain
469
Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
469
Opioid Receptors: Overview
584
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
584
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
153
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
153
Opioid Analgesics: Synthetic and Semisynthetic Opioids
246
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
246

